Financial Statements — GLRE
Balance Sheet
(in billions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 0.08 | 0.07 | 0.08 | 0.05 | 0.05 | 0.05 | 0.06 | 0.04 | 0.06 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 |
| Total Assets | 2.27 | 2.13 | 2.19 | 2.15 | 2.00 | 1.90 | 1.88 | 1.74 | 1.72 | 1.64 | 1.52 | 1.49 | 1.47 | 1.41 | 1.42 | 1.42 |
| Long-term Debt | 0.00 | 0.03 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Liabilities | 1.53 | 1.48 | 1.52 | 1.49 | 1.34 | 1.27 | 1.25 | 1.16 | 1.15 | 1.13 | 1.06 | 1.01 | 1.00 | 0.96 | 0.96 | 0.95 |
| Retained Earnings | 0.26 | 0.18 | 0.18 | 0.18 | 0.18 | 0.14 | 0.14 | 0.09 | 0.08 | 0.03 | (0.01) | 0.00 | (0.01) | (0.03) | (0.02) | (0.02) |
| Total Stockholder Equity | 0.74 | 0.66 | 0.66 | 0.67 | 0.66 | 0.63 | 0.62 | 0.58 | 0.56 | 0.51 | 0.47 | 0.48 | 0.47 | 0.45 | 0.47 | 0.47 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Net Premiums Earned | 154.15 | 165.62 | 165.42 | 161.64 | 168.46 | 148.14 | 151.88 | 158.40 | 161.54 | 137.45 | 163.11 | 139.94 | 142.65 | 111.39 | 121.95 | 110.22 | 125.93 | 135.88 | 135.52 | 132.48 |
| Net Investment Income | 6.73 | 8.65 | (2.95) | 10.47 | 8.29 | 11.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Revenue | 189.66 | 210.30 | 146.07 | 160.11 | 213.30 | 141.84 | 188.01 | 174.86 | 191.31 | 155.49 | 166.92 | 189.69 | 154.99 | 145.51 | 126.72 | 121.42 | 133.03 | 164.38 | 139.23 | 134.52 |
| Benefits & Claims | 91.16 | 100.04 | 88.59 | 100.08 | 122.88 | 122.75 | 93.17 | 102.03 | 109.33 | 75.93 | 96.84 | 90.50 | 96.73 | 63.70 | 94.56 | 60.82 | 97.41 | 79.90 | 110.40 | 86.96 |
| Total Benefits & Expenses | 153.79 | 159.69 | 149.95 | 159.43 | 182.39 | 170.19 | 152.05 | 166.45 | 163.78 | 137.89 | 153.42 | 139.80 | 149.04 | 110.76 | 146.01 | 106.62 | 138.77 | 140.07 | 153.09 | 133.89 |
| Tax Provision | 0.12 | 1.33 | 0.53 | 0.35 | 1.28 | (0.93) | 0.72 | 0.44 | 0.52 | (0.01) | 0.03 | 0.03 | 0.05 | 0.01 | (0.82) | 0.01 | (0.02) | 0.01 | 0.00 | -0.00 |
| Net Income | 35.75 | 49.28 | (4.40) | 0.33 | 29.63 | (27.42) | 35.24 | 7.98 | 27.02 | 17.61 | 13.48 | 49.86 | 5.89 | 34.75 | (18.47) | 14.79 | (5.73) | 24.30 | (13.85) | 0.63 |
| Diluted EPS | 1.05 | 1.43 | (0.13) | 0.01 | 0.86 | (0.78) | 1.01 | 0.23 | 0.78 | 0.62 | 0.39 | 1.32 | 0.17 | 1.09 | (0.56) | 0.37 | (0.17) | 0.72 | (0.42) | 0.02 |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Operating Cash Flow | 37.24 | 100.21 | 31.18 | 68.44 | 10.38 | 29.53 | 41.30 | 22.71 | 17.96 | 22.14 | (15.20) | 1.83 | (1.26) | (4.37) | (13.41) | (2.40) | (11.62) | (37.52) | 1.06 | (1.09) |
| Capital Expenditures | 0.03 | 0.19 | 0.25 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow* | 37.21 | 100.02 | 30.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Investing Cash Flow | (66.09) | (76.96) | (9.27) | (46.94) | (15.99) | 0.66 | (26.98) | (40.41) | (29.83) | (30.58) | (15.50) | 15.03 | (22.08) | 42.78 | 3.60 | (32.62) | 33.26 | 18.70 | (12.76) | 21.49 |
| Financing Cash Flow | (4.99) | (32.83) | (25.44) | (5.94) | (0.94) | (1.88) | (7.49) | (10.94) | (0.94) | 0.00 | 11.79 | 0.00 | (17.08) | (13.41) | (6.42) | 0.00 | -- | 0.00 | (3.25) | (6.75) |
* Derived from reported values
